Newcastle scientists get UK's first stem cell license

Scientists based at Newcastle's Center for Life (http://www.centreforlife.co.uk) have been granted permission to carry out pioneering research to create stem cells from unfertilized human eggs.

This is the first time in the UK that such a license has been granted. It could help scientists understand how diseases develop and may lead to the development of new treatments for a range of diseases including Alzheimer's and Parkinson's and diabetes.

The decision puts the UK at the forefront of global research in this very promising area of medicine and confirms North East England's status as one of the world's emerging centers for biomedical research.

The Newcastle Human Embryonic Stem Cell Group, part of the government sponsored Life Knowledge Park(LKP), is now launching a funding appeal to accelerate research. It is seeking private sector partners to help the UK stay ahead of international competition.

The group was established two years ago, in a joint venture involving the NHS, Newcastle University and the Center for Life with funding from the Departments of Health and Trade and Industry and from the regional development Agency, One NorthEast. Its remit is to explore the potential offered by stem cells to understand and develop possible new therapies for many serious and debilitating diseases.

In early 2003 it became one of the first two groups in the UK to derive human ES (embryonic stem) cells from spare IVF embryos. Two members of the group, Professor Alison Murdoch of the Newcastle NHS Fertility Centerand Dr. Miodrag Stojkovic, a Reader in Stem Cell Biology and Embryology at Newcastle University, applied to the Human Embryology and Fertilization Authority (HFEA) for the license to undertake 'somatic cell nuclear transfer', as it is known scientifically, in February 2004.

Professor M

Contact: Makeda Scott
British Information Services

Page: 1 2 3 4

Related biology news :

1. Therapeutic cloning may be permitted at Newcastle University
2. Exotic Newcastle disease
3. DNA lends scientists a hand, revealing new chemical reactions
4. Conference at UH opens doors for new scientists, engineers
5. Wisconsin scientists develop quick botox test
6. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
7. Alaska scientists find Arctic tundra yields surprising carbon loss
8. UAF scientists discover new marine habitat in Alaska
9. Information system to help scientists analyze mechanisms of social behavior
10. Zoonotic diseases - European scientists unite to fight diseases
11. Israeli scientists reveal the plan of a key cellular machine

Post Your Comments:

(Date:1/23/2020)... ... 23, 2020 , ... GIOSTAR/HEAMGEN has developed and ... The red blood cells are made utilizing a bioreactor that permits the ... and replaces the need for a human blood donor. GIOSTAR/HEAMGEN mature ...
(Date:1/22/2020)... ... January 21, 2020 , ... Astro Pak’s president Ken Carroll ... Department. The move, which is part of the company’s structural reorganization, was announced ... Senior Vice President where he oversaw its Cleanroom Division as well as both ...
(Date:1/10/2020)... , ... January 09, 2020 , ... ... bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of the ... interbody fusion system. , The EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... BOSTON (PRWEB) , ... February ... ... privately-owned company) is pleased to announce the successful results from a long-term ... stenosis using the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block ...
(Date:2/10/2020)... , ... February 10, 2020 , ... R3 Medical Training ... March 13-14th, 2020 in Las Vegas. The course is hands on involving real ... For the past few years, the Comprehensive Stem Cell Training Course has received rave ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , ... The National Organization for Rare Disorders (NORD), to raise awareness amongst the general public ... The Balancing Act’s “Behind The Mystery” rare disease series will be ...
(Date:2/3/2020)... , ... February 03, 2020 , ... ... in Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex successor to ... is a best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping ...
Breaking Biology Technology:
Cached News: